Clinical Research Directory
Browse clinical research sites, groups, and studies.
Real-World Patient and Physician Experience With Semaglutide Across Six Emerging Markets
Sponsor: Novo Nordisk A/S
Summary
The purpose of this study is to assess semaglutide's impact on daily life from participants and physicians experience.
Official title: sEMa-LIFE: Unveiling Semaglutide's Impact on Daily Life - Patient and Physicians Experience Across Six Emerging Markets
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1260
Start Date
2026-08-28
Completion Date
2026-08-31
Last Updated
2026-09-30
Healthy Volunteers
No
Conditions
Interventions
Semaglutide
This is a retrospective, non-interventional study; therefore, no intervention was administered as part of the study.
Locations (6)
Novo Nordisk Investigational Site
Jerusalem, Israel
Novo Nordisk Investigational Site
Mexico City, Mexico
Novo Nordisk Investigational Site
Riyadh, Saudi Arabia
Novo Nordisk Investigational Site
Pretoria, South Africa
Novo Nordisk Investigational Site
Ankara, Turkey (Türkiye)
Novo Nordisk Investigational Site
Abu Dhabi, United Arab Emirates